Stock APYX APYX MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Apyx Medical Corporation

Equities

APYX

US03837C1062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
1.32 USD +4.76% Intraday chart for Apyx Medical Corporation -5.04% -49.62%
Apr. 05 Archon Capital Management Engages with Apyx Medical Corporation CI
Apr. 01 Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS' SUMMIT
AQ
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
BU
Archon Capital Management Engages with Apyx Medical Corporation
CI
Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation
CI
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS, INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK
AQ
Transcript : Apyx Medical Corporation, Q4 2023 Earnings Call, Mar 21, 2024
Apyx: Q4 Earnings Snapshot
AQ
Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
BU
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024
CI
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Investors -2-
DJ
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
BU
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY SCIENTIFIC MEETING
AQ
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
BU
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY
AQ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
BU
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
CI
Apyx Medical Reports Q4, Full-Year 2023 Preliminary Revenue
MT
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APYX Stock
  4. News Apyx Medical Corporation